| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Karbe Frank is a Director at Phathom Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $10.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 12,500 | $7.93 | $99,083.75 | +28.1% | -46.5% | +84.5% |